Trials & Tribulations All colorectal cancer patients require germline testing at diagnosis and somatic testing at advanced disease diagnosis July 15, 2022Vol.48 No.28By Wenora Johnson, Danielle Ripley-Burgess, Heather Hampel, Folasade (Fola) P. May, Anjee Davis and Richard M. Goldberg
Capitol Hill NIH-funded institutions must report sexual misconduct cases within 30 days, effective July 9 July 15, 2022Vol.48 No.28By Matthew Bin Han Ong
Capitol HillConversation with The Cancer Letter Shikha Jain, Shea Holman examine NIH’s new requirements for institutions to report misconduct July 15, 2022Vol.48 No.28By Matthew Bin Han Ong
FreeObituary Herman Suit, whose research underpinned precision radiation and proton beam therapy, dies at 93 July 15, 2022Vol.48 No.28By Anthony L. Zietman
FreeIn the Archives John Ultmann: Founding director of UChicago Cancer Research Center July 15, 2022Vol.48 No.28
Trials & Tribulations Burnout from the elusive quest for quality July 15, 2022Vol.48 No.28By Banu E. Symington
Conversation with The Cancer Letter Karen Knudsen: Lessons learned while rebuilding the American Cancer Society July 08, 2022Vol.48 No.27By Paul Goldberg
Conversation with The Cancer Letter Roy Jensen describes KU’s 18-year path to Comprehensive designation July 08, 2022Vol.48 No.27By Paul Goldberg
Conversation with The Cancer LetterFree Ohio State’s Alice Mims: Six-week abortion ban places oncologists in jeopardy July 08, 2022Vol.48 No.27By Alice Tracey
FreeGuest Editorial Abortion care, cancer, and the fate of American physicians July 08, 2022Vol.48 No.27By Annabella Denzel, Theresa Rohr-Kirchgraber and Laura Rush
